Search research articles
Contact Us
Filters
Showing results (391-400 of 551) with videos related to
Page
of 56
Sort By:
Leukemia Research
|
January 1, 1992
The combination of quercetin and cytosine arabinoside synergistically inhibits leukemic cell growth
L Teofili, L Pierelli, M S Iovino, et al.
International Journal of Cancer
|
February 1, 1992
Growth-inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumors
F O Ranelletti, R Ricci, L M Larocca, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
December 17, 2008
Sonographic features of primary ovarian fibrosarcoma: a report of two cases
A C Testa, A Gaurilcikas, A Licameli, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
June 30, 2017
Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta-analysis
G Calì, I E Timor-Tritsch, J Palacios-Jaraquemada, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 26, 1998
Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer
P Benedetti-Panici, S Greggi, G Scambia, et al.
Bone Marrow Transplantation
|
May 1, 1991
Autologous bone marrow processing for autotransplantation using an automated cell processor and a semiautomated procedure
L Pierelli, G Menichella, R Serafini, et al.
Anti-Cancer Drug Design
|
September 1, 1995
Effect of synthetic and naturally occurring chalcones on ovarian cancer cell growth: structure-activity relationships
R De Vincenzo, G Scambia, P Benedetti Panici, et al.
Gynecologic Oncology
|
July 25, 2020
Bevacizumab as maintenance treatment in BRCA mutated patients with advanced ovarian cancer: A large, retrospective, multicenter case-control study
D Lorusso, C Marchetti, C Conte, et al.
Cancer Chemotherapy and Pharmacology
|
September 13, 2011
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy
S Pignata, F Amant, G Scambia, et al.
Experimental Hematology
|
May 17, 2000
The fusion protein MEN 11303 (granulocyte-macrophage colony stimulating factor/erythropoietin) acts as a potent inducer of erythropoiesis
A Battaglia, A Fattorossi, L Pierelli, et al.
Page
of 56
Search research articles
Search
Showing results (391-400 of 551) with videos related to
Sort By:
Page
of 56
Leukemia Research
|
January 1, 1992
The combination of quercetin and cytosine arabinoside synergistically inhibits leukemic cell growth
L Teofili, L Pierelli, M S Iovino, et al.
International Journal of Cancer
|
February 1, 1992
Growth-inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumors
F O Ranelletti, R Ricci, L M Larocca, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
December 17, 2008
Sonographic features of primary ovarian fibrosarcoma: a report of two cases
A C Testa, A Gaurilcikas, A Licameli, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
June 30, 2017
Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta-analysis
G Calì, I E Timor-Tritsch, J Palacios-Jaraquemada, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 26, 1998
Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer
P Benedetti-Panici, S Greggi, G Scambia, et al.
Bone Marrow Transplantation
|
May 1, 1991
Autologous bone marrow processing for autotransplantation using an automated cell processor and a semiautomated procedure
L Pierelli, G Menichella, R Serafini, et al.
Anti-Cancer Drug Design
|
September 1, 1995
Effect of synthetic and naturally occurring chalcones on ovarian cancer cell growth: structure-activity relationships
R De Vincenzo, G Scambia, P Benedetti Panici, et al.
Gynecologic Oncology
|
July 25, 2020
Bevacizumab as maintenance treatment in BRCA mutated patients with advanced ovarian cancer: A large, retrospective, multicenter case-control study
D Lorusso, C Marchetti, C Conte, et al.
Cancer Chemotherapy and Pharmacology
|
September 13, 2011
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy
S Pignata, F Amant, G Scambia, et al.
Experimental Hematology
|
May 17, 2000
The fusion protein MEN 11303 (granulocyte-macrophage colony stimulating factor/erythropoietin) acts as a potent inducer of erythropoiesis
A Battaglia, A Fattorossi, L Pierelli, et al.
Page
of 56